MeiraGTx Holdings (MGTX) Work In Process (2022 - 2023)

MeiraGTx Holdings (MGTX) posted Work In Process of $732000.0 for Q3 2023, down 1.35% on a QoQ basis from $742000.0 in Q4 2022.

MeiraGTx Holdings (MGTX) Work In Process (2022 - 2023) Analysis & Trends

MeiraGTx Holdings' Work In Process history runs 2 years deep, the most recent figure standing at $732000.0 for Q3 2023.

  • Quarterly Work In Process changed N/A year-over-year to $732000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $732000.0 (changed N/A YoY) and the FY2022 annual result came in at $742000.0, changed N/A from the prior year.
  • Work In Process was $732000.0 for Q3 2023 at MeiraGTx Holdings, down from $742000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $742000.0 in Q4 2022 and bottomed at $732000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 MeiraGTx Holdings 973.21 Mn 907.27 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 732,000.00
Dec 31, 2022 742,000.00